netFormulary
 Report : A-Z HCD items in Formulary 25/01/2021 01:41:55
[Back]
 
Section Status BlueTeq Name
01.05.03 Formulary BlueTeq Adalimumab 
02.12 Formulary BlueTeq Alirocumab Praluent®
13.05.02 Formulary BlueTeq Apremilast Otezla®
09.01.04 Formulary BlueTeq Avatrombopag Doptelet®
04.12 Formulary BlueTeq Botulinum neurotoxin Type A Xeomin®
09.01.04 Formulary BlueTeq Eltrombopag  Revolade®
02.12 Formulary BlueTeq Evolocumab Repatha®
06.01.06 Formulary BlueTeq Flash glucose monitoring system FreeStyle Libre®
04.07.04.02 Formulary BlueTeq Fremanezumab 
01.05.03 Formulary BlueTeq Golimumab Simponi®
01.05.03 Formulary BlueTeq Infliximab 
09.01.04 Formulary BlueTeq Lusutrombopag Mulpleo®
03.04.02 Restricted Use BlueTeq Omalizumab 
13.05.03 Formulary BlueTeq Risankizumab Skyrizi®
09.01.04 Formulary BlueTeq Romiplostim Nplate®
01.05.03 Formulary BlueTeq Tofacitinib Xeljanz®
10.01.03 Formulary BlueTeq Tofacitinib  Xeljanz ®
01.05.03 Formulary BlueTeq Ustekinumab Stelara®
13.05.03 Formulary BlueTeq Ustekinumab 
01.05.03 Formulary BlueTeq Vedolizumab Entyvio®
South Staffordshire Joint Formulary